STEMCULTURES, LLC

Biotech · Private

DISC™ device—a controlled-release bioengineered insert delivering human recombinant growth factors to replace fetal bovine serum in cell culture media

Grants
$2.0M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Controlled-release Microbeads to Replace Growth Factors in Fetal Bovine Serum$225,501
Federal grantDepartment of Health and Human Services · Phase II · Controlled-release Microbeads to Replace Growth Factors in Fetal Bovine Serum$903,045
Federal grantDepartment of Health and Human Services · Phase II · Controlled-release Microbeads to Replace Growth Factors in Fetal Bovine Serum$826,379
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
3082Altigg Therapeutics, Inc.——
3083Ventus Therapeutics——
3084EVINCIS BIO, INC.——
3085STEMCULTURES, LLC——
3086COALA BIOSCIENCES——
3087INTERVENTIONAL ANALGESIX, INC.——
3088HOLOCLARA, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.